New Study Highlights Links Between Huanan Seafood Market and Initial SARS-CoV2 Outbreak 28/07/2022 Raisa Santos The Huanan Wholesale Seafood Market in Wuhan, China, was the epicenter of the early outbreaks of SARS-CoV2, a new, peer-reviewed study asserts, following its examination of early COVID-19 cases in the region and environmental samples originating from the market. The study, published by Science Magazine, reinforces the theory that the emergence of SARS-COV2 occurred via […] Continue reading -> Acute Childhood Hepatitis Cases – Scottish Researchers May Have Unraveled Mystery 25/07/2022 Elaine Ruth Fletcher The mystery around the rash of acute, serious hepatitis cases that have afflicted over 1000 children under the age of 16 may have been unravelled by a group of Scottish researchers who say that the interaction of two common adenoviruses, or related herpes viruses, may have caused the condition in genetically susceptible children who failed […] Continue reading -> WHO Issues Stiff Warnings as COVID Cases Double and Monkeypox Expands Reach 21/07/2022 Elaine Ruth Fletcher WHO has issued stiff, dual warnings over a surging global rate of COVID infections alongside a still-expanding outbreak of Monkeypox. The latter is set to be the focus of a discussion by a WHO Emergency Committee meeting Thursday, as the committee reconvenes to decide if a public health emergency should be declared over the virus […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Acute Childhood Hepatitis Cases – Scottish Researchers May Have Unraveled Mystery 25/07/2022 Elaine Ruth Fletcher The mystery around the rash of acute, serious hepatitis cases that have afflicted over 1000 children under the age of 16 may have been unravelled by a group of Scottish researchers who say that the interaction of two common adenoviruses, or related herpes viruses, may have caused the condition in genetically susceptible children who failed […] Continue reading -> WHO Issues Stiff Warnings as COVID Cases Double and Monkeypox Expands Reach 21/07/2022 Elaine Ruth Fletcher WHO has issued stiff, dual warnings over a surging global rate of COVID infections alongside a still-expanding outbreak of Monkeypox. The latter is set to be the focus of a discussion by a WHO Emergency Committee meeting Thursday, as the committee reconvenes to decide if a public health emergency should be declared over the virus […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues Stiff Warnings as COVID Cases Double and Monkeypox Expands Reach 21/07/2022 Elaine Ruth Fletcher WHO has issued stiff, dual warnings over a surging global rate of COVID infections alongside a still-expanding outbreak of Monkeypox. The latter is set to be the focus of a discussion by a WHO Emergency Committee meeting Thursday, as the committee reconvenes to decide if a public health emergency should be declared over the virus […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older posts